1. Introduction {#sec1}
===============

In the last twenty years, the field of bronchoscopy has become increasingly more complex and invasive. It is now widely used in the diagnosis and management of pulmonary diseases and has the benefit of low mortality and complication rates. Complication and mortality rates range from 1.1% to 32% and 0%--0.8% respectively depending on studies [@bib1]. Potential complications of bronchoscopy may include bleeding, desaturation, and rarely pneumothorax [@bib1]. However, facial and neck petechiae associated with subcutaneous hemorrhage post-bronchoscopy has not been reported before in the literature.

We hereby report two unusual cases of facial/neck petechiae post-bronchoscopy as a complication to be recognized by bronchoscopists. The clinical presentation was visually alarming but self-resolving phenomenon. We discuss the possible etiology of this complication and how it can be prevented in the future.

2. Case 1 {#sec2}
=========

A 60-year old lady, a non-smoker, non-drinker, was admitted with an exacerbation of asthma. Past medical history included allergic rhinitis, asthma with no known allergies. She was not on any anticoagulation or antiplatelet therapy.

She initially responded to nebulisation, prednisolone 30 mg daily and intensive chest physiotherapy. However, she developed a right lower lung lobe collapse was transferred to a high dependency unit for bronchoscopy to rule out foreign body obstruction and for airway toilet to re-expand the right lower lobe.

Bronchoscopy via nasal intubation was performed with 5mg of intravenous midazolam, 50mcg of fentanyl. No intra-nasal lignocaine spray was used during the intubation. Dynamic airway collapse in the trachea and bronchus with copious clear mucoid secretions was seen throughout with no evidence of foreign body or stricture. The procedure took 10 minutes and was uncomplicated, apart from usual minor retching and coughing.

An hour after the bronchoscopy, a non-blanching petechial rash appeared over the face and neck, not affecting the rest of her body ([Fig. 1](#fig1){ref-type="fig"}). Pemberton\'s test was negative. She remained haemodynamically stable. Investigations revealed normal clotting, bleeding profile with stable Hb. The patient was reassured after an explanation of its benign nature. The rash had almost fully disappeared in two days.

3. Case 2 {#sec3}
=========

A 27-year old, non-smoking, non-drinking gentleman was admitted with a persistent cough and dysphonia. Three weeks prior to admission, he suffered chemical burns from a chemical leak composing of hydrogen peroxide, acetic acid and peracetic acid, which had caused inhalational injury with vocal cord chemical injury, complicated with persistent moderate to severe dysphonia.

His past medical history included hypertension controlled with oral anti-hypertensives and had no known allergies. He was not on any anti-coagulation or anti-platelet therapy.

He was treated with naproxen for cough-induced pleuritic chest pain. High-resolution CT scan showed pneumonitis and nodular infiltrates in the right lower lobe, suggestive of infection. Pulmonary function testing showed a restrictive picture. He was then started on tapering high-dose prednisolone starting from 30mg for treatment of pneumonitis. Both naproxen and prednisolone were served in the morning of bronchoscopy.

Bronchoscopy and BAL was then performed to re-inspect the airway and to rule out infection. Bronchoscopy via nasal intubation was performed with 5mg of intravenous midazolam and 5 sprays of 4.5% intra-nasal lignocaine. The vocal cords were noted to be sloughy with cord irregular nodularity but no ulceration or erythema was noted in the major tracheobronchial trees. Patient\'s blood pressure was stable during the procedure and was kept sedated with a mean sedation score of 2. The procedure lasted 15 mins and was uncomplicated.

Two hours after bronchoscopy, a non-blanching, non-palpable petechial rash appeared over the face and neck, with the rest of his body remaining unaffected ([Fig. 2](#fig2){ref-type="fig"}). The patient remained well and haemodynamically stable. Blood tests revealed normal clotting and bleeding profile with stable Hb. A platelet aggregation test were performed on the patient and was mildly impaired, likely secondary to the use of naproxen. Naproxen was immediately stopped. The rash subsequently improved over the next seven days.

4. Discussion {#sec4}
=============

This case series report presents two unusual cases of facial petechiae developing in patients after bronchoscopy.

Diagnosis of endoscopy-related bleeding involves the exclusion of vasculitic, coagulopathic, neoplastic, infectious, and other causes. Common characteristics pointing to endoscopy-related bleeding include no history of vasculitis or coagulopathies; normal blood works; superficial lesions such as petechiae; predominantly facial and/or neck distribution during or soon after endoscopic procedure or natural regression of lesion within 7--10 days etc ([Table 1](#tbl1){ref-type="table"}).

COX-inhibitors prevent the formation of thromboxane A2 [@bib13], thereby impairing thromboxane-dependent platelet aggregation and prolonging bleeding time. Both patients were given either a NSAID or COX inhibitor before the bronschoscopy.

It therefore may be a consideration to be stop short-acting NSAIDS at least one day before surgery (14,15) However, as the complication of petechiae is relatively benign, the risks of suspending these medications may outweigh any potential risk reduction. The British Thoracic Society guidelines currently state that aspirin can be continued during diagnostic endoscopic procedures [@bib1].

We cannot exclude other factors which would have increased their risk of facial capillary rupture during aggravation by bronchoscopy. The first patient had been undergoing intensive chest physiotherapy shortly before bronchoscopy, and the second patient was mildly hypertensive during the bronchoscopy and had poorly-controlled pre-existing cough from pneumonitis. We postulate that factors such as hypertension and incessant coughing can potentially aggravate capillary pressure. Attempts to achieve optimal control prior to bronchoscopy may be helpful in lowering the risk. Bronchoscopy can also be timed in elective cases in which procedures involving Valsalva manoeuvres, such as pulmonary function testing, should not be too closely scheduled. Using adequate sedation and local anaesthesia to suppress the gag or cough reflex may potentially reduce this risk, although this must be balanced with the risks of sedation and anaesthesia.

Although facial and neck petechiae post bronchoscopy is a rather dramatic clinical presentation, the natural history is relatively benign, self-limiting and patient would recover spontaneously and hence both physicians and patients need not be unduly alarmed. It might be a useful exercise to consider factors which could potentially contribute to this phenomenon though it is beyond the scope of this report to ascertain if this rare phenomenon can be completely pre-empted and prevented.
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![Non-blanching petechial rash appearing on the neck and face an hour after bronchoscopy.](gr1){#fig1}

![Facial and neck petechiae 2 h post-bronchoscopy in a 27-year old gentleman.](gr2){#fig2}

###### 

Common characteristics of endoscopic procedures that lead to report of facial or neck purpura/petechiae or subconjunctival haemorrhage.

Table 1

                                            Pappas et al., 1984 [@bib3]                                                                 Tóth et al., 1998 [@bib11]                                                                  Rajvanshi and McDonald 2001 [@bib2]                                 Adişen et al., 2007 [@bib10]                           Ozaslan et al., 2010 [@bib9]                                              Christou et al., 2011            Yüksel et al., 2012                            Balta et al., 2014
  ----------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------------------------- -------------------------------- ---------------------------------------------- ------------------------------------------------
  Age                                       32                                                                                          35                                                                                          59                                                                  43                                                     31                                                                        60                               73                                             60
  Gender                                    Female                                                                                      Female                                                                                      Male                                                                Female                                                 Male                                                                      Male                             Female                                         Male
  Pre-existing comorbidities                None                                                                                        Left sided migraine -- normal CT scan                                                       Agnoggenic myeloid metaplasia, myelofibrosis, portal hypertension   None                                                   None                                                                      None                             None                                           None
  Procedure and indication                  Gastroscopy for intermittent dysphagia of solids and liquids -- antral gastritis detected   Gastroscopy for suspected haematemsis                                                       OGD for oesophageal varices                                         OGD for gastritis                                      OGD for dyspeptic complaints                                              OGD for persistent dyspepsia     OGD for anaemia -- antral gastritis detected   OGD
  Complications                             Minimal gagging                                                                             Moderate retching                                                                           Moderate retching                                                   Aborted procedure due to appearance of rash            Repeated retching and coughing                                            Looked mildly strained           Coughing and retching                          Not stated
  Sedation                                  Meperidine and diazepam                                                                     Not stated                                                                                  IV Midazolam (4mg) and fentanyl (100μg)                             Not stated                                             None                                                                      IV Midazolam (2mg)               Oral lidocaine spray                           Oral lidocaine spray
  Use of antiplatelet/anticoagulant/NSAID   Several days\' history of aminosalicyclic acid ingestion                                    None                                                                                        None                                                                None                                                   None                                                                      None                             None                                           None
  Clotting profile                          Normal platelet count, PT, bleeding time, Rumpel-Leede test                                 Not stated                                                                                  Platelets 22 × 10^6^/μL before transfusion, 67 × 10^6^/μL after     Normal FBC, PT, PTT                                    Normal FBC, biochemistry, PT, PTT                                         Normal platelets, PT, PTT        Hb 10.3 g/, normal PT, PTT, INR                Normal FBC, PT, PTT
  Characteristic of lesion                  Bilateral subconjunctival haemorrhage and diffuse facial and neck petechiae                 Orbital haematoma causing displacement of the left eye; ecchymosis of eyelid on left side   Bloody tears from subconjunctival haemorrhage                       Facial and neck purpura; subconjunctival haemorrhage   Multiple petechiae, diffuse oedema on face, subconjunctival haemorrhage   Facial petechiae                 Facial ecchymosis and purpura                  Facial purpura and subconjunctival haemorrhage
  Time started                              'Shortly after'                                                                             Immediately after                                                                           Immediately after                                                   During endoscopy                                       Immediately after                                                         A few minutes after              A few hours after                              During endoscopy
  Time to resolution                        10 days                                                                                     By 3 weeks\' follow up                                                                      7 days (at follow up)                                               4 days                                                 5 days                                                                    Not stated, gradually subsided   10 days (at follow up)                         5 days
  Treatment                                 None                                                                                        None                                                                                        None                                                                None                                                   Steroid ointment on 2nd day at patient\'s request                         Not stated                       None                                           None
